Less Invasive Aortic Valve Surgery

Similar documents
Surgery: The Gold Standard treatment for Aortic Stenosis

Measuring the risk in valve patients Lessons learnt from the TAVI story? Bernard Iung Bichat Hospital, Paris, France

TAVR and Cardiac Surgeons

Minimally invasive aortic valve surgery: new solutions to old problems.

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea

TAVI Versus Suturless Valve In Intermediate Risk Patients

Five-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in Inoperable Patients With Severe Aortic Stenosis: The PARTNER Trial

Management of Difficult Aortic Root, Old and New solutions

CARDIOCHIRURGIA MINI-INVASIVA: INVASIVA: efficacia per il paziente efficienza per la sanita. Dott. Davide Ricci

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?

IPAC date: May of 13

Dr Nikolaos Baikoussis

National Institute for Health and Care Excellence IP865/2 Sutureless Aortic Valve Replacement for aortic stenosis

Valve Replacement without a Scalpel Transcatheter Aortic Valve Replacement (TAVR) Charles T. Klodell, M.D.

Rapid deployment aortic valve replacement for the treatment of severe aortic stenosis in high risk patients. Β. Κόλλιας, Σ. Ματιάτου, Δ. Αγγουράς.

Essential Support for a Structural Heart Program: The Valve and Structural Heart Clinic

2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route

Percutaneous aortic valve replacement should NOT be preferred therapy for aortic stenosis

Edwards Transcatheter AVR: Have the Outcomes Changed after CE Approval?

Role of Sutureless Valves in the Surgeon s Armamentarium Prof. Dr Malakh Shrestha Vice Chair, Director of Aortic Surgery Cardiothoracic,

Patient selection for transcatheter aortic valve implantation (TAVI) in South Africa

Heart Team For TAVI Who and How?

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Policy Specific Section: March 30, 2012 March 7, 2013

VALVULOPATIE: NUOVE SOLUZIONI.

Minimally Invasive Aortic Surgery With Emphasis On Technical Aspects, Extracorporeal Circulation Management And Cardioplegic Techniques

Results of Transapical Valves. A.P. Kappetein Dept Cardio-thoracic surgery

Standard AVR. Full Sternotomy CPB

For the SURTAVI Investigators

TAVI Summit Eberhard Grube MD FACC, FSCAI Universitätsklinik Bonn, Medizinische Klinik und Poliklinik II, Bonn, Germany

TAVI: The Real Deal? Marc Pelletier, MD Head, Department of Cardiac Surgery New Brunswick Heart Centre

When Should We Consider TAVI. (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea

Transcatheter Therapies For Aortic Valve Disease. March 2017 Brian Whisenant MD

Transcatheter Aortic Valve Implantation Anaesthetic Prespectives

Transcatheter Aortic Valve Replacement TAVR

First Transfemoral Aortic Valve Implantation In Bulgaria - Crossing The Valve With The Device Is Not Always

Transcatheter Aortic Valve Implantation (TAVI) Overview for Wales. Dr Richard Anderson University Hospital of Wales, Cardiff, UK

Assessment and Preparation of Patients with TAVI. Rob Tanzola Associate Professor, Queen s University

Innovative ECMO Configurations in Adults

RISK PREDICTION IN TAVR. Beyond STS PROM and the Eyeball Assessment

Aortic Stenosis. Information on anatomy, diagnosis and treatment options

Valvular Intervention

Minimally invasive aortic valve replacement in high risk patient groups

Alternate Vascular Access for TAVR. Gian Paolo Ussia Campus Bio-medico University, Rome Italy

Developments in Valve Surgery

Establishing a New Path Forward for Patients With Severe Symptomatic Aortic Stenosis THE PARTNER TRIAL CLINICAL RESULTS

RANDOMISED TRIALS TAVI WITH SAVR STEPHAN WINDECKER AORTIC VALVE DISEASE COMPARING

Interventional procedures guidance Published: 26 July 2017 nice.org.uk/guidance/ipg586

Appropriate Patient Selection or Healthcare Rationing? Lessons from Surgical Aortic Valve Replacement in The PARTNER I Trial Wilson Y.

Is it a business for the cardiac surgeon?

TAVR SPRING 2017 The evolution of TAVR

AVR with Sutureless Valves State of the Art

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504

TAVR for low-risk patients in 2017: not so fast.

Prof. Dr. Thomas Walther. TAVI in ascending aorta / aortic root dilatation

TRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH

TRANSAPICAL AORTIC VALVE REPAIR

Transcatheter Aortic Valve Implantation Procedure (TAVI)

Aortic Stenosis: Background

A new option for the Diagnosis and Management of Valvular Heart Disease. Oregon Comprehensive Valve Center

Prince Sultan Cardiac Center Experience Riyadh, Saudi Arabia

Summary Transcatheter aortic valve implantation: Evaluation of the evidence and synthesis of organizational issues

Minimally invasive aortic valve surgery: state of the art and future directions

Transcatheter aortic valve implantation for severe aortic stenosis a new paradigm for multidisciplinary intervention: A prospective cohort study

TAVI: 10 Years After the First Case Low-Risk and High-Risk Patients What are the Limits? Dr Bernard Prendergast DM FRCP FESC John Radcliffe Hospital

A COMMISSIONING FRAMEWORK FOR TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) FOR SEVERE SYMPTOMATIC AORTIC STENOSIS

Objectives. Describe a multidisciplinary team and it s utilization in the inpatient cardiovascular surgical patient

MINIMALLY INVASIVE AVR

Clinical Commissioning Policy: Transcatheter Aortic Valve Implantation (TAVI) For Aortic Stenosis. December Reference : NHSCB/A10/a/1

Percutaneous Aortic Valvuloplasty: Long-Term Survival

An Update on the Edwards TAVR Results. Zvonimir Krajcer, MD Director, Peripheral Intervention Texas Heart Institute at St.

Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI)

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

Neal Kleiman, MD Houston Methodist DeBakey Heart and Vascular Institute

The Impact of TAVI Nurse Coordinator on patient management of Transcatheter Aortic Valve Implantation (TAVI) program in QEH

INNOVATION IN CARDIOVASCULAR MEDICINE. AORTA CLINIC. Dr. Jaime Camacho M. Director, Aorta Clinic

REDUCING THE IMPACT OF SURGERY AND FACILITATING FASTER RECOVERY

TAVI: Nouveaux Horizons

Transcatheter aortic valve implantation for aortic stenosis

TAVR 2018: Cost-effective according to baseline patient risk. A real-world case example

Transcatheter Aortic-Valve Implantation for Aortic Stenosis

The Role of TAVI in high-risk and normal-risk Patients

evidence note Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults who are not eligible for surgery

TAVI at Liverpool Heart & Chest Hospital. National Audit of Cardiac Services in Wales Wrexham 28/11/2012

Aortic Stenosis in the Elderly: Difficulties for the Clinician. Are Symptoms Due to Aortic Stenosis?

Next Generation Therapies: Aortic, Mitral and Beyond

Masterclass III Advances in cardiac intervention. Percutaneous valvular intervention a novel approach

PhD in Bioengineering and Medical-Surgical Sciences

Fast track surgery: the role of the surgeon Enrico Ferrari, MD University of Lausanne, Switzerland

Transcatheter Aortic Valve Replacement (TAVR)

Transcatheter aortic valve implantation and pre-procedural risk assesment

Cardiac Valve/Structural Therapies

Transcatheter aortic valve replacement is considered investigational for all other indications.

42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim

Update on Percutaneous Therapies for Structural Heart Disease. William Thomas MD Director of Structural Heart Program Tucson Medical Center

Aortic valve replacement with sutureless and rapid deployment aortic valve prostheses

Edwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved

TAVR (Transcatheter Aortic Valve Replacement).

Transcription:

Less Invasive Aortic Valve Surgery SCTS Brighton 19th March 2013 Andrew Chukwuemeka MD FRCS Consultant Cardiothoracic Surgeon Hammersmith Hospital Imperial College Healthcare NHS Trust

Less Invasive Aortic Valve Surgery TAVI New valves Sutureless, rapid deployment, AVR Incisions Mini-sternotomy / mini-thoracotomy Mini-CPB

Aortic valve surgery in the UK

Is this safe?

Valve Surgery in Octogenarians: A Safe Option with Good Medium-Term Results Andrew Chukwuemeka, Michael A. Borger, Joan Ivanov, Susan Armstrong, Christopher M. Feindel, Tirone E. David Division of Cardiovascular Surgery, Toronto General Hospital and Department of Surgery, University of Toronto Conclusion: Valve surgery in selected octogenarians is associated with low morbidity and mortality. The outlook after surgery is very good, and surgery should not be denied to this group on the basis of age alone. The Journal of Heart Valve Disease 2006;15:191-196

Euro Heart Survey A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003 Jul;24(13):1231-43 1 in 3 patients with severe symptomatic AS did not have surgery

Unmet need in severe AS Charlson E et al. Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis 2006;15:312-321 Iung B et al. A prospective survey of patients with valvular heart disease in Europe:The Euro Heart Survey on Valvular Heart Disease. European Heart Journal 2003;24:1231-1243 60% 32% Bouma B J et al. To operate or not on elderly patients with aortic stenosis:the decision and its consequences. Heart 1999;82:143-148 41%

Unmet need in severe AS Charlson E et al. Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis 2006;15:312-321 Iung B et al. A prospective survey of patients with valvular heart disease in Europe:The Euro Heart Survey on Valvular Heart Disease. European Heart Journal 2003;24:1231-1243 60% 32% Bouma B J et al. To operate or not on elderly patients with aortic stenosis:the decision and its consequences. Heart 1999;82:143-148 41% TAVI is a much needed alternative to conventional AVR

What is TAVI (R)?

Less Invasive Aortic Valve Surgery - TAVI Access routes: Transfemoral Transapical Direct aortic Subclavian (axillary) Iliac +/- conduit Depends on: patient anatomy team preference experience

Ann Thorac Surg. 2005 May;79(5):1812-8

Multidisciplinary approach Heart Team

TAVI team Cardiac surgeons Interventional cardiologists Imaging cardiologists Radiologists Elderly care physicians Anaesthetist Critical care physicians Specialist nurses Physiotherapists Occupational therapists Rehabilitation Perfusionists Operating theatre team Psychologists

TAVI patient selection Anatomically suitable, inoperable or very high-risk, severe symptomatic AS Elderly (but not exclusively) Co-morbidities respiratory, renal, poor LV, hepatic ++++ Contraindication to AVR porcelain aorta, mediastinal radiation Risk score (STS >10%, EuroSCORE >20%) Frailty

Frailty in TAVI Frail Patients Are at Increased Risk for Mortality and Prolonged Institutional Care After Cardiac Surgery. Circulation 2010;121:973-8 Complex interaction between age and chronic illness Chronological age is not the same as biological age Subjective Parameters: gait, 5m walk speed, grip strength, ADL, biological markers (albumin, bilirubin, lung function tests), +++

Frailty in TAVI

Risk scoring in TAVI

Risk scoring in TAVI

TAVI RESULTS PARTNER B

PARTNER B - NYHA

PARTNER A: UPDATE 2 year results PARAVALVULAR LEAK

PARTNER A: UPDATE 2 year results

The future of TAVI? Improving patient selection ( picking the winners ) Improving technology (access, paravalvular leak, stroke) Adhering to established principles (durability etc.)

Major Dwight Harken US Army 133 consecutive survivors First series of successful open heart operations

Ten Commandments - Dwight Harken It must not propagate emboli It must be chemically inert and not damage blood elements It must offer no resistance to physiological flows It must close promptly It must remain closed during the appropriate phase of the cardiac cycle It must have lasting physical and geometric features It must be inserted in a physiological site It must not annoy the patient It must be capable of permanent fixation It must be technically practical to insert A A device is safe when it is safer than the condition it corrects

New valve technology Sutureless AVR:

PERCEVAL S sutureless AVR Dedicated tools facilitate visibility at the implant site and accurate valve positioning As supplied Collapsed Ready to implant Perceval S Valve collapsing Valve collapsed to a reduced diameter (not crimped)

Sutureless AVR -Potential benefits Ease of implantation resulting in a shorter cross-clamp clamp and cardiopulmonary bypass time High-risk comorbidities, advanced age Concomitant cardiac procedures Adhere to established surgical principles (unlike TAVI) Annular decalcification (emboli, paravalvular leak) Direct vision

IMPLANTATION Ready to implant Valve deployment Implant Valve is collapsed to a reduced diameter 2-Step Deployment & Balloon Dilatation Valve is positioned in aorta

IMPLANTATION

Sutureless AVR HAMMERSMITH EXPERIENCE Total n=17 Age Range: 76 90 Mean: 85.6 yrs +/- 5.9 Gender Female: 6 (35%) Male: 11 (65%) Logistic Euroscore Range: 9.76 49.75 Mean: 20.9 +/- 13.8

Sutureless AVR HAMMERSMITH EXPERIENCE Procedure AVR only 12 (61%) AVR + CABG 5 (29%) Bypass Time Range: 49 77min Mean: 59.4min +/- 11.6 Valve Sizes S 5 M 8 L 4 Cross-clamp Time Range: 27 58min Mean: 44.1min +/- 10.4

Sutureless AVR HAMMERSMITH EXPERIENCE

Minimally-invasive aortic surgery

Minimally-invasive AVR Ministernotomy versus conventional sternotomy for aortic valve replacement: A systematic review and meta-analysis. Morgan L. Brown, MD, Stephen H. McKellar, MD, Thoralf M. Sundt, MD, and Hartzell V. Schaff, MD Conclusion: Ministernotomy can be performed safely for aortic valve replacement, without increased risk of death or other major complication; however, few objective advantages have been shown. Surgeons must conduct well-designed, prospective studies of relevant, consistent clinical outcomes to determine the role of ministernotomy in cardiac surgery. Brown et al. JTCVS March 2009

Marginal benefit wrt mortality, ICU stay. Longer CPB and XC time Patient choice Cosmesis

Cardiopulmonary bypass Cardioplegic arrest in diastole Bloodless operative field Detrimental effects of extracorporeal circulation Risks vs. benefits

Miniature Cardiopulmonary Bypass 1. Optimise venous drainage 2. Minimise microair 3. Minimise surface contact 4. Minimise blood damage 5. Minimise haemodilution

Optimise Venous Drainage Controlled Kinetic Venous Drainage Smaller cannula 29 French Many draining holes Holes set into grooves Long cannula Improves Liver/ GIT drainage?

Minimise Microair 300ml/min 5sec 120µ filter Pump flow Active rather than Passive air removal Perthel M, El-Ayoubi L, Bendisch A, Laas J, Gerigk M. Clinical advantages of using mini-bypass systems in terms of blood product use, postoperative bleeding and air entrainment: an in vivo clinical perspective. Eur J Cardio-thorac Surg 2007;31:1070-75.

Minimise Surface Contact Oxygenator is the largest non-physiological surface in CPB circuit 1.8m 2 Gas Exchange Surface Area 1.1m 2 Gas Exchange Surface Area

Minimise Blood Damage Well Managed Suction/Vent Blood ( Air Mixing and -P) Poorly Managed Suction/Vent Blood ( Air Mixing and -P)

Minimise Haemodilution Patient Specific Volume Strategy NOT Volume Restrictive Retrograde Autologous Prime Antegrade Autologous Prime

Less Invasive Aortic Valve Surgery TAVI New valves Sutureless, rapid deployment, AVR Incisions Mini-sternotomy / mini-thoracotomy Mini-CPB

In times of change, the learners inherit the Earth while the learned find themselves beautifully equipped to deal with a world that no longer exists.